All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 188 of 206 pages ‹ First < 186 187 188 189 190 > Last ›
HSL4035
Berube B.
Marketing ibuprofen
Canadian Pharmaceutical Journal 1990;123:402
HSL4036
Berube B.
The slick sell: the pharmacist’s view
Canadian Pharmaceutical Journal 1990;123:400-401
HSL4037
Berube B.
The subtle sell: an overview
Canadian Pharmaceutical Journal 1990;123:397-398
HSL4038
Berube B.
Who regulates drug advertising in Canada
Canadian Pharmaceutical Journal 1990;123:402, 418
HSL4039
Ethical responsibilities of physicians in their dealings with pharmaceutical companies
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:45-48
HSL4040
Blouin , C .
Hypertension and eating habits
Canadian Medical Association Journal 1990;143:460-461
HSL4041
Bricker EM.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4042
Burkle JS.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407-408
HSL4043
Bushe CJ.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:65
HSL4047
Canavan B.
Forging the alliance: CME’s relationship with industry
Journal of Continuing Education in the Health Professions 1990;10:123-128
HSL4048
Chetley A.
A healthy business? World health and the pharmaceutical industry
Zed Books 1990;
http://www.amazon.com/Healthy-Business-Health-Pharmaceutical-Industry/dp/0862327350/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1174978013&sr=1-1
HSL4049
Chren MM, Landefeld CS, Murray TH.
Doctors, drug companies, and gifts
JAMA 1990;263:2178-2179
HSL4050
Cockerill R.
Report on the 1989 survey of the dispensing practices and attitudes toward prescription drugs of Ontario pharmacists
1990;
HSL4052
Double standard labelling of pharmaceuticals sold in Thailand
Drug Study Group 1990;3
HSL4053
Duffin JM.
Junk mail
Canadian Medical Association Journal 1990;142:708
HSL4055
Erola J.
A sample response
Canadian Medical Association Journal 1990;143:129
HSL4056
Feather KR.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:659
HSL4057
Gall JM.
Medifacts tapes and general practice
Canadian Family Physician 1990;36:419
HSL4058
Gelbart H.
Doctors, drug companies, and gifts
JAMA 1990;263:2177
HSL4059
Glass AR.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4060
Goldstein M.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407
HSL4062
Gorski TN.
Doctors, drug companies, and gifts
JAMA 1990;263:2177
HSL4065
Herxheimer A.
Medicines in francophone Africa
Lancet 1990;335:1449-1450
HSL4067
Hume AL.
Doctors, drug companies, and gifts
JAMA 1990;263:2177-2178
HSL4068
Jason KM.
Persantine advertisement: artistic license or misleading implication?
JAMA 1990;263:658-659
HSL4070
Jones K.
Advertising acyclovir
Lancet 1990;335:732
HSL4072
Kimbel KH.
Advertorials?
Lancet 1990;336:496
HSL4073
Lexchin J.
Disinformation from pharmaceutical company representatives
Canadian Medical Association Journal 1990;143:370
HSL4074
Lexchin J.
Drug makers and drug regulators: too close for comfort: A study of the Canadian situation
Social Science and Medicine 1990;31:1257-1263
HSL4075
Lexchin J.
The portrayal of the elderly in drug advertisements: a factor in inappropriate prescribing?
Canadian Journal on Aging 1990;9:296-303
HSL4076
Lexchin J.
Prescribing by Canadian general practitioners: review of the English language literature
Canadian Family Physician 1990;36:465-470
HSL4078
McSherry J.
Medifacts tapes and advertising
Canadian Family Physician 1990;36:850
HSL4079
Strom B.
Notes of the American Society for Clinical Pharmacology and Therapeutics: Position paper on the use of purported postmarketing drug surveillance studies for promotional purposes
Clinical Pharmacology and Therapeutics 1990;48:598
HSL4080
Morris LA, Banks DB.
New issues in drug advertising and labeling: the five advertising end-runs
Drug Information Journal 1990;24:639-646
HSL4082
Ethical aspects of phamaceutically based clinical investigation
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:436-438
HSL4084
Nidiry JJ.
Doctors, drug companies, and gifts
JAMA 1990;263:2178
HSL4085
Noble RC.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:408
HSL4086
Noble RC.
The pizza parade
Annals of Internal Medicine 1990;112:237
HSL4087
Odenbach E.
Collaboration with commercial interests in continuing medical education
Journal of Continuing Education in the Health Professions 1990;10:293-301
HSL4088
Peay MY, Peay ER.
Patterns of preference for information sources in the adoption of new drugs by specialists.
Soc Sci Med 1990;31:(4):467-76
HSL4090
Potter HP.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407
HSL4091
Pye J.
“Disinformation” from pharmaceutical company representatives
Canadian Medical Association Journal 1990;142:1178
HSL4093
Relman AS.
More on sex and racial bais in pharmaceutical advertisements
New England Journal of Medicine 1990;322:1534
HSL4094
Rendle MA.
Zopiclone (Imovane): evaluation in general practice
New Zealand Medical Journal 1990;103:225
HSL4096
Robertson WO.
Throw-away journals
Canadian Medical Association Journal 1990;142:708
HSL4097
Robinson WK.
A sample argument
Canadian Medical Association Journal 1990;143:611
HSL4098
Rodwin MA.
Industrial marketing and medical ethics
New England Journal of Medicine 1990;322:64
HSL4099
Roeg N.
The other drug trade
Adbusters 1990;1:(4):80-87
www.adbusters.org/adbusters/
HSL4100
Russell R, Nelson PJ, Ohri L.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:64-65
HSL4103
Scherr L.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:408
HSL4109
Shepherd R.
Junk mail
Canadian Medical Association Journal 1990;143:14
HSL4110
Shickman MD.
CME’s relationship with industry
Journal of Continuing Education in the Health Professions 1990;10:189-190
HSL4111
Shulkin D.
Physicians and the pharmaceutical industry
Annals of Internal Medicine 1990;113:407
HSL4113
Solomon SD.
Ethical guidelines for promotion of prescription drugs to physicians
New England Journal of Medicine 1990;322:65
HSL4114
Squires BP.
Editors and advertisers
Canadian Medical Association Journal 1990;143:167
HSL4115
Squires BP.
PAAB: a lesson in self-government
Canadian Medical Association Journal 1990;143:1151
HSL4116
Stein U.
Ginkgo biloba extracts
Lancet 1990;335:475-476
HSL4118
Information or communication? A consumer study of television advertising
Taylor Nelson Research 1990;
HSL4119
Thomas M, Lexchin J.
Responsiveness to physicians' requests for information concerning drug interactions: a comparison of brand and generic companies.
Soc Sci Med 1990;31:(2):153-7
HSL4122
Tilyard MW, Dovey SM.
Placement of advertisements
New Zealand Medical Journal 1990;103:382
HSL4123
Timpany J.
A sample argument
Canadian Medical Association Journal 1990;143:129
HSL4124
Tomson G, Angunawela I.
Patients, doctors and their drugs. A study at four levels of health care in an area of Sri Lanka
European Journal of Clinical Pharmacology 1990;39:463-467
HSL4125
Tomson G, Weerasuriya K.
'Codes' and practice: information in drug advertisements--an example from Sri Lanka.
Soc Sci Med 1990;31:(7):737-41
HSL4126
Van HR, Mazmanian PE, Osborne CE.
Commercial support for CME courses sponsored by medical schools
Journal of Continuing Education in the Health Professions 1990;10:197-210
HSL4127
Venturelli J.
Medical ethics: a dilemma at our doorstep
Annals of the Royal College of Physicians and Surgeons of Canada 1990;23:335
HSL4129
Williams AP, Cockerill R.
Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians
1990;
HSL4130
Williams EB.
Advertising acyclovir
Lancet 1990;335:288
HSL4131
Zaini J.
Pushing children’s vitamins
HAI News 1990;(51):1-2, 11
HSL4136
Cohen EP.
Are pharmaceutical ads good medicine?
Business and Society Review 1990;73:8-10
HSL4137
Secunda E.
Is TV addicted to drug company PR?
Business and Society Review 1990;73:11-14
HSL4145
Hamer P.
More medication for healthy women!
DES Action Canada Newsletter 1990;(23):1-2
www.web.net/~desact
HSL9482
Halperin JA.
Strategic issues in the Rx-to-OTC switch
Drug Information Journal 1990;24:(1):13-18
HSL9483
Schondelmeyer SW.
Economic aspects of switch
Drug Information Journal 1990;24:(1):57-66
HSL9488
Mela S.
European communities: outstanding white paper proposals for the completion of internal market in the pharmaceutical sector
Drug Information Journal 1990;24:(3):635-638
HSL9490
Monk MR, Smith M.
Product portfolio analysis: SmithKline to SmithKline Beecham
Journal of Pharmaceutical Marketing Management 1990;4:(4):85-96
HSL19871
Morris LA, Banks DB
New Issues in Drug Advertising and Labeling: The Five Advertising End-Runs
Drug Information Journal 1990;24:639-646
http://dij.sagepub.com/content/24/3/639.abstract
HSL20489
Miller C, Clark B
Medicine ads misleading say lobby group
The Herald 1989 Dec 13
HSL9521
Conlan MF.
Drug industry must hold down Medicaid costs or states will
Drug Topics 1989 Dec 11;133:48
HSL19886
Randall H
Drug Promotional Problem Dec 1989
MJA 1989 Dec;151:(532):653
HSL3984
Wade VA, Mansfield PR, McDonald PJ.
Drug companies' evidence to justify advertising.
Lancet 1989 Nov 25;2:(8674):1261-3
HSL15824
Rodwin MA.
Physicians' conflicts of interest. The limitations of disclosure
NEJM 1989 Nov 16;321:(20):1405-1408
http://content.nejm.org/cgi/content/brief/321/20/1405
HSL19911
SKF Withdraws APMA Resignation
Australian Pharmaceutical Manufacturers Association 1989 Nov 10
HSL4021
Wilkes MS, Shuchman M.
Pitching doctors.
N Y Times Mag 1989 Nov 5;88, 90, 126, 128-129
HSL4019
MaLAM letter follow up—Merck Sharp & Dohme. Are MSD’s distributors uncontrollable?
MaLAM Newsletter 1989 Nov;
HSL4020
Re: the promotion of uridine triphosphate
1989 Nov;
HSL9519
Prescription drugs: ready for prime time?
National Association of Retail Druggists Journal 1989 Nov;111:26-27, 29-30
HSL9520
West CM.
Independent retail pharmacy in a free-market economy
National Association of Retail Druggists Journal 1989 Nov;111:54-57
HSL19912
Margo J
APMA withdraws news release
The Sydney Morning Herald 1989 Oct 307
HSL19910
Margo J
Drug Firm Quits After Findings on Complaints
The Sydney Morning Herald 1989 Oct 267
http://newsstore.smh.com.au/apps/viewDocument.ac?page=1&sy=smh&kw=Drug+firm+quits+after+findings+on+complaints&pb=smh&dt=selectRange&dr=entire&so=relevance&sf=text&sf=headline&rc=10&rm=200&sp=nrm&clsPage=1&docID=news891025_0291_2188
HSL4017
Cearnal ME.
Journal advertising works
Medical Marketing & Media 1989 Oct 20;24:(12):4,6-10
HSL20484
MaLAM's open letter to industry
Scrip 1989 Oct 20;(1457):22
HSL4013
Re: the promotion of DPT-P vaccine
1989 Oct;
HSL4014
MaLAM letter follow up—Wellcome: a welcome withdrawal
MaLAM Newsletter 1989 Oct;
HSL4015
Re: the promotion of Franol combination for asthma
1989 Oct;
HSL9516
Gervas JJ.
Analysis of the factors inducing the prescription
Farmacia Clinica 1989 Oct;6:588-590, 592-594
HSL9518
Johnson RC.
Seeking sanity in an insane world
California Pharmacist 1989 Oct;37:24, 26-27
HSL9537
Zellmer WA.
Generic drug products.
Am J Hosp Pharm 1989 Oct;46:(10):2005
HSL16719
Wolfe SM.
The right to know belatedly comes to the health care system.
Internist 1989 Oct;30:(9):12-4
http://www.ncbi.nlm.nih.gov/pubmed/10295873
HSL3962
Lexchin J.
Declaration of vested interest.
Lancet 1989 Sep 30;2:(8666):806
HSL3936
Engler RL.
The arrhythmia consultation program.
N Engl J Med 1989 Sep 28;321:(13):908
Page 188 of 206 pages ‹ First < 186 187 188 189 190 > Last ›
